Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
Should you bet on an established giant or a pipeline-driven innovator? This comparison examines Amgen (NASDAQ:AMGN) and Moderna…
‘No longer proven to outweigh its risks’: Ireland pulls medication linked to 20 deaths in Japan
A medication used to treat rare autoimmune diseases has been pulled from shelves in Ireland after regulators revisited…
Colorado can’t cap price of arthritis drug Enbrel, judge rules
Colorado can’t cap the price of arthritis medication Enbrel while a lawsuit challenging the state’s drug affordability board’s…
Nearly 1 million bottles of heart, kidney medications recalled nationwide over ‘foreign substance’
Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly…
Colorado’s first-of-its-kind price cap on an Amgen drug blocked
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Common kidney, heart meds recalled due to ‘foreign substance’
(NewsNation) — The U.S. Food and Drug Administration announced nearly one million bottles of commonly used heart and…
The next goal for weight loss drugs? Fewer injections
For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It…
Trump announces 100% tariff on pharma imports – The Irish Times
Most Irish pharmaceutical exports look set to escape 100 per cent tariffs announced overnight by the Trump administration.…
Amgen seeks six-storey car park on Dublin site as it expects to add 1,000 jobs – The Irish Times
Biopharma group Amgen says it expects employment at the Irish arm of its business to jump by 40…
How The Shutdown Impacts Healthcare
In this week’s edition of InnovationRx, we look at the shutdown’s impact on healthcare, the Nobel Prize winners…
These 20 companies still love remote work
Across much of America, workers fear their options for remote work are slipping away. The news cycle churns…
A Once-in-a-Decade Opportunity: 10 Billion Reasons to Pay Attention to This Monster Quantum Computing Company (Hint: Not IonQ)
When investors think about quantum computing stocks, IonQ is often one of the first names that comes to…